ArticleCancers2021

Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs.

Abed Agbarya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.